This cross-sectional study of U.S. adults from the 2017–2018 NHANES cycle found that current marijuana use was associated with a lower prevalence of liver steatosis. No significant association was found between marijuana use and liver fibrosis.
PLOS ONE · 10 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This cross-sectional study of U.S. adults from the 2017–2018 NHANES cycle found that current marijuana use was associated with a lower prevalence of liver steatosis. No significant association was found between marijuana use and liver fibrosis.
After adjusting for confounders, current marijuana use was independently associated with a lower prevalence of liver steatosis (P = 0.048), but no significant association was found with liver fibrosis in univariate or multivariate analyses. The findings suggest an inverse association between current marijuana use and liver steatosis in the general population, but the pathophysiology is unclear and requires further longitudinal research.